Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angelini Fine Chemicals is the Contract Development and Manufacturing Organization (CDMO) division of Angelini Pharma, a prominent Italian pharmaceutical group. The company specializes in the custom synthesis and GMP manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for the global pharmaceutical industry. Operating from an FDA-inspected facility in Aprilia, Italy, they offer a comprehensive range of services from early-stage process development and scale-up to full-scale commercial production. Their technical expertise includes complex small molecule chemistry, high-potency APIs (HPAPIs), and flow chemistry applications. Angelini Fine Chemicals serves as a strategic partner for both virtual biotech firms and large pharmaceutical companies, providing integrated solutions for drug substance manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Angelini Fine Chemicals.